Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker

Haematologica 2026 Open access

Read full text

Authors: Ariel Israel, Roi Gat, Howard S. Oster, Yakir Moshe, Itamar Raz, Moshe Mittelman, Eugene Merzon

DOI: 10.3324/haematol.2025.300022

Cited by: 0

Fields of Study & Subjects

Acute Myeloid Leukemia Research Diabetes Management and Research Hemoglobinopathies and Related Disorders